From viruses to cancer stem cells: Dissecting the pathways to malignancy

Veterinary Journal

Volumn 177, Issue 3, 2008, Pages 311-323

  Argyle, David J ^a   Blacking, Thalia ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cancer; Dog; Stem cell; Therapies; Viral oncogenesis

Indexed keywords

ANTINEOPLASTIC AGENT; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; IMATINIB; NUCLEAR PROTEIN; PROTEIN KINASE; PROTEIN MDM2; PROTEIN P53; RETINOBLASTOMA PROTEIN;

CANCER GROWTH; CANCER INVASION; CANCER RELAPSE; CANCER STEM CELL; CANCER SURVIVAL; CARCINOGENESIS; CELL DIVISION; CELL PROLIFERATION; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; DINOSAUR; DNA VIRUS; DRUG TARGETING; FOSSIL; GENE AMPLIFICATION; HUMAN; JURASSIC; LYMPHATIC SYSTEM; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MOLECULAR DYNAMICS; NONHUMAN; OVERALL SURVIVAL; POINT MUTATION; RETROVIRUS; REVIEW; STOCHASTIC MODEL; SYSTEMIC CIRCULATION; TUMOR SUPPRESSOR GENE; VERTEBRATE; VIRUS CARCINOGENESIS;

ANIMALS; ANTINEOPLASTIC AGENTS; HUMANS; MUTATION; NEOPLASTIC STEM CELLS; ONCOGENES; RESEARCH; STOCHASTIC PROCESSES; TRANSLOCATION, GENETIC; TUMOR VIRUS INFECTIONS;

CANIS FAMILIARIS; DECAPODA (CRUSTACEA); DINOSAURIA; VERTEBRATA;

EID: 45949109970     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2007.09.017     Document Type: Review

References (70)

1. Al-Hajj M., and Clarke M.F. Self-renewal and solid tumour stem cells. Oncogene 23 (2004) 7274-7282
2. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., and Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences USA 100 (2003) 3983-3988
3. Argyle D.J., and Khanna C. The Biology of Cancer. In: Withrow S.J., and Vail D.M. (Eds). Small Animal Clinical Oncology (2006), Elsevier 31-53
4. Balic M., Lin H., Young L., Hawes D., Giuliano A., McNamara G., Datar R.H., and Cote R.J. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast CSC phenotype. Clinical Cancer Research 12 (2006) 5615-5621
5. Behbod F., and Rosen K.M. Will cancer stem cells provide new therapeutic targets?. Carcinogenesis 26 (2005) 703-711
6. Bhatia R., Holtz M., Niu N., Gray R., Snyder D.S., Sawyers C.L., Arber D.A., Slovak M.L., and Forman S.J. Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment. Blood 101 (2003) 4701-4707
7. Bjerkvig R., Tysnes B.B., Aboody K.S., Najbauer J., and Terzis A.J.A. Opinion: the origin of the cancer stem cell: current controversies and new insights. Nature Reviews Cancer 5 (2005) 899-904
8. Bonnet D., and Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine 3 (1997) 730-737
9. Brabletz T., Jung A., Spaderna S., Hlubek F., and Kirchner T. Opinion: migrating cancer stem cells-an integrated concept of malignant tumour progression. Nature Reviews Cancer 5 (2005) 744-749
10. Bunting K.D. ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cells 20 (2002) 11-20
11. Campo M.S., Jarrett W.F., Barron R., O'Neil B.W., and Smith K.T. Association of bovine papillomavirus type 2 and bracken fern with bladder cancer in cattle. Cancer Research 52 (1992) 6898-6904
12. Campo M.S., O'Neil B.W., Barron R.J., and Jarrett W.F. Experimental reproduction of the papilloma-carcinoma complex of the alimentary canal in cattle. Carcinogenesis 8 (1994) 1597-1601
13. Carrillo-Infante C., Abbadessa G., Bagella L., and Gordionao A. Viral infections as a cause of cancer. International Journal of Cancer 30 (2007) 1521-1528
14. Dontu G., Abdallah W.M., Foley J.M., Jackson K.W., Clarke M.F., Kawamura M.J., and Wicha M.S. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes and Development 17 (2003) 1253-1270
15. Doyle L.A., and Ross D.D. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 22 (2003) 7340-7358
16. Evan G., and Littlewood T. A matter of life and cell death. Science 281 (1998) 1317-1322
17. Fidler I.J., and Hart I.R. Biological diversity in metastatic neoplasms: origins and implications. Science 217 (1982) 998-1003
18. Fidler I.J., and Kripke M.L. Metastasis results from preexisting variant cells within a malignant tumor. Science 197 (1977) 893-895
19. Fuster J.J., Sanz-Gonzalez S.M., Moll U.M., and Adres V. Classic and novel roles of p53: prospects for anticancer therapy. Trends in Molecular Medicine 13 (2007) 192-199
20. Gaukroger J.M., Bradley A., Chandrachud L., Jarrett W.F., and Campo M.S. Interaction between bovine papillomavirus type 4 and cocarcinogens in the production of malignant tumours. Journal of General Virology 74 (1993) 2275-2280
21. Gillet N., Florins A., Boxus M., and Willems L. Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human. Retrovirology 4 (2007) Art. 18 MAR 16
22. Goodell M.A., Rosenzweig M., Kim H., Marks D.F., DeMaria M., Paradis G., Grupp S.A., Sieff C.A., Mulligan R.C., and Johnson R.P. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nature Medicine 3 (1997) 1337-1345
23. Gorlick R., Anderson P., Andrulis I., Arndt C., Beardsley G.P., Bernstein M., Bridge J., Cheung N.K., Dome J.S., Ebb D., Gardner T., Gebhardt M., Grier H., Hansen M., Healey J., Helman L., Hock J., Houghton J., Houghton P., Huvos A., Khanna C., Kieran M., Kleinerman E., Ladanyi M., Lau C., Malkin D., Marina N., Meltzer P., Meyers P., Schofield D., Schwartz C., Smith M.A., Toretsky J., Tsokos M., Wexler L., Wigginton J., Withrow S., Schoenfeldt M., and Anderson B. Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary. Clinical Cancer Research 9 (2003) 5442-5453
24. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
25. Harris C.C. p53 tumor suppressor gene: from the basic research laboratory to the clinic - an abridged historical perspective. Carcinogenesis 17 (1996) 1187-1198
26. Haupt Y., Maya R., Kazaz A., and Oren M. Mdm2 promotes the rapid degradation of p53. Nature 387 (1997) 296-299
27. Heaney N.C.B., and Holyoake T.L. Therapeutic targets in chronic myeloid leukaemia. Hematological Oncology 25 (2007) 66-75
28. Hemmati H.D., Nakano I., Lazareff J.A., Masterman-Smith M., Geschwind D.H., Bronner-Fraser M., and Kornblum H.I. Cancerous stem cells can arise from pediatric brain tumors. Proceedings of the National Academy of Sciences USA 100 (2003) 15178-15183
29. Heppner G.H. Tumor heterogeneity. Cancer Research 44 (1984) 2259-2265
30. Houghton J., Stoicov C., Nomura S., Rogers A.B., Carlson J., Li H.C., Cai X., Fox J.G., Goldenring J.R., and Wang T.C. Gastric cancer originating from bone marrow-derived cells. Science 306 (2004) 1568-1571
31. Huntly B.J., and Gilliland D.G. Leukaemia stem cells and the evolution of cancer-stem-cell research. Nature Reviews Cancer 5 (2005) 311-321
32. Huff C.A., Matsui W.H., Smith B.D., and Jones R.J. Strategies to eliminate cancer stem cells: clinical implications. European Journal of Cancer 42 (2006) 1293-1297
33. Ignatova T.N., Kukekov V.G., Laywell E.D., Suslov O.N., Vrionis F.D., and Steindler D.A. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 39 (2002) 193-206
34. Jain M., Arvanitis C., Chu K., Dewey W., Leonhardt E., Trinh M., Sundberg C.D., Bishop J.M., and Felsher D.W. Sustained loss of a neoplastic phenotype by brief inactivation of MYC. Science 297 (2002) 102-104
35. Jarrett O., and Onions D. Leukaemogenic Viruses. In: Whittaker J.A. (Ed). Leukaemia. second ed. (1992), Blackwell's Scientific Publications, Oxford 34-63
36. Kamel-Reid S., Letarte M., Sirard C., Doedens M., Grunberger T., Fulop G., Freedman M.H., Philips R.A., and Dick J.E. A model of human acute lymphoblastic leukemia in immune-deficient SCID mice. Science 246 (1989) 1597-1600
37. Kaplan R.N., Riba R.D., Zacharoulis S., Bramley A.H., Vincent L., Costa C., MacDonald D.D., Jin D.K., Shido K., Kerns S.A., Zhu Z.P., Hicklin D., Wu Y., Port J.L., Altorki N., Port E.R., Ruggero D., Shmelkov S.V., Jensen K.K., Rafii S., and Lyden D. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438 (2005) 820-827
38. Keith B., and Simon M.C. Hypoxia-inducible factors, stem cells and cancer. Cell 129 (2007) 465-472
39. Khanna C., Lindblad-Toh K., Vail D., London C., Bergman P., Barber L., Breen M., Kitchell B., McNeil E., Modiano J.F., Niemi S., Comstock K.E., Ostrander E., Westmoreland S., and Withrow S. The dog as a cancer model. Nature Biotechnology 24 (2006) 1065-1066
40. Knudsen E.S., Sexton C.R., and Mayhew C.N. Role of the retinoblastoma tumor suppressor in the maintenance of genome integrity. Current Molecular Medicine 7 (2006) 749-757
41. Konstantinopoulos P.A., Karamouzis M.V., and Papavassiliou A.G. Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets. Nature Reviews Drug Discovery 6 (2007) 540-555
42. Kucia M., Reca R., Miekus K., Wanzeck J., Wojakowski W., Janowska-Wieczorek A., Ratajczak J., and Ratajczak M.Z. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 23 (2005) 879-894
43. Lane D.P. P53: Guardian of the genome. Nature 358 (1992) 15-16
44. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Cacerescortes J., Minden M., Paterson B., Caligiuri M.A., and Dick J.E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367 (1994) 645-648
45. Lapidot T., Dar A., and Kollet O. How do stem cells find their way home?. Blood 106 (2005) 1901-1910
46. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 88 (1997) 323-331
47. Macpherson H., Keir P., Webb S., Samuel K., Boyle S., Bickmore W., Forrester L., and Dorin J. Bone marrow-derived SP cells can contribute to the respiratory tract of mice in vivo. Journal of Cell Science 118 (2005) 2441-2450
48. McCance K.L., and Roberts L.K. The Biology of Cancer. In: McCance K.L., and Huether S.E. (Eds). Pathophysiology. The Biological Basis of Disease in Adults and Children (1997), Mosby 304-349
49. Moore K.A., and Lemischka I.R. Stem cells and their niches. Science 311 (2006) 1880-1885
50. Mueller M.M., and Fusing N.E. Friends or foes - bipolar effects of the tumour stroma in cancer. Nature Reviews Cancer 4 (2004) 839-849
51. Nasir L., Rutteman G.R., Reid S.W.J., Schulze C., and Argyle D.J. Analysis of p53 mutational events and MDM2 amplification in canine soft-tissue sarcomas. Cancer Letters 174 (2001) 83-89
52. Neil J.C., Hughs D., McFarlane R., Wilkie E.M., Onions D.E., Lees G., and Jarrett O. Transduction and rearrangement of the myc gene by feline leukaemia virus in naturally occurring T cell leukaemias. Nature 308 (1984) 814-820
53. Nowell P.C. Mechanisms of tumor progression. Cancer Research 46 (1986) 2203-2207
54. O'Brien C.A., Pollett A., Gallinger S., and Dick J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445 (2007) 106-110
55. Pardal R., Clarke M.F., and Morrison S.J. Applying the principles of stem-cell biology to cancer. Nature Reviews Cancer 3 (2003) 895-902
56. Park C.H., Bergsagel D.E., and McCulloc E.A. Mouse Myeloma Tumour Stem Cells: Primary Cell Culture Assay. Journal of the National Cancer Institute 46 (1971) 411-422
57. Polyak K., and Hahn W.C. Roots and stems: stem cells in cancer. Nature Medicine 12 (2006) 296-300
58. Reya T., Morrison S.J., Clarke M.F., and Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 414 (2001) 105-111
59. Reynolds B.A., Tetzlaff W., and Weiss S. A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. Journal of Neuroscience 12 (1992) 4565-4574
60. Scharenberg C.W., Harkey M.A., and Torok-Storb B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 99 (2002) 507-512
61. Sell S. Stem cell origin of cancer and differentiation therapy. Critical Reviews in Oncology and Hematology 51 (2004) 1-28
62. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., and Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Research 63 (2003) 5821-5828
63. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., and Dirks P.B. Identification of human brain tumour initiating cells. Nature 432 (2004) 396-401
64. Sirard C., Lapidot T., Vormoor J., Cashman J.D., Doedens M., Murdoch B., Jamal N., Messner H., Addey L., Minden M., Laraya P., Keating A., Eaves A., Lansdorp P.M., Eaves C.J., and Dick J.E. Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis. Blood 87 (1996) 1539-1548
65. Southam C.M., and Brunschwig A. Quantitative studies of autotransplantation of human cancer. Cancer 14 (1961) 971-978
66. Taipale J., and Beachy P.A. The Hedgehog and Wnt signalling pathways in cancer. Nature 411 (2001) 349-354
67. Terskikh A.V., Easterday M.C., Li L.H., Hood L., Kornblum H.I., Geschwind D.H., and Weissman I.L. From hematopoiesis to neuropoiesis: evidence of overlapping genetic programs. Proceedings of the National Academy of Sciences USA 98 (2001) 7934-7939
68. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell 81 (1995) 323-330
69. Wilson, H., Huelsmeyer, M., Chun, R., Young, K.M., Friedrichs, K., Argyle, D.J., in press. Isolation and characterisation of cancer stem cells from canine osteosarcoma. The Veterinary Journal.
70. Zhou S., Schuetz J.D., Bunting K.D., Colapietro A.M., Sampath J., Morris J.J., Lagutina I., Grosveld G.C., Osawa M., Nakauchi H., and Sorrentino B.P. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nature Medicine 7 (2001) 1028-1034